ReposiTrak (NYSE:TRAK) Releases Quarterly Earnings Results

Key Points

• ReposiTrak reported quarterly earnings of $0.09 per share, with a net margin of 30.13% and a return on equity of 13.89%.
• The company's stock price decreased by 0.9% to $16.77, and it has experienced a one-year trading range between $15.12 and $25.01.
• Institutional investors have shown significant interest, with some increasing their positions by over 397% in the last quarter, leading to institutional ownership of 27.35% of the company's stock.

ReposiTrak (NYSE:TRAK - ) released its quarterly earnings data on Monday. The company reported $0.09 earnings per share for the quarter, Zacks reports. ReposiTrak had a net margin of 30.13% and a return on equity of 13.89%.

ReposiTrak Trading Down 0.9%

Shares of ReposiTrak stock traded down $0.16 during trading on Monday, hitting $16.77. 83,431 shares of the stock were exchanged, compared to its average volume of 50,489. ReposiTrak has a 1-year low of $15.12 and a 1-year high of $25.01. The firm has a market cap of $306.56 million, a PE ratio of 49.32 and a beta of 0.47. The stock has a fifty day moving average of $16.91. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03.

Insider Buying and Selling

In related news, CEO Randall K. Fields sold 7,500 shares of the company's stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $16.06, for a total value of $120,450.00. Following the transaction, the chief executive officer owned 87,000 shares in the company, valued at approximately $1,397,220. This represents a 7.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have sold 85,874 shares of company stock valued at $1,494,513. 44.00% of the stock is currently owned by corporate insiders.

Institutional Trading of ReposiTrak

Institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Financial Markets increased its position in shares of ReposiTrak by 63.5% during the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after buying an additional 634 shares during the period. Tower Research Capital LLC TRC grew its stake in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock valued at $71,000 after acquiring an additional 2,892 shares in the last quarter. Rhumbline Advisers grew its stake in ReposiTrak by 69.1% during the second quarter. Rhumbline Advisers now owns 18,036 shares of the company's stock valued at $354,000 after acquiring an additional 7,371 shares in the last quarter. American Century Companies Inc. grew its stake in ReposiTrak by 17.4% during the second quarter. American Century Companies Inc. now owns 23,344 shares of the company's stock valued at $459,000 after acquiring an additional 3,455 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in ReposiTrak during the second quarter valued at approximately $802,000. Institutional investors own 27.35% of the company's stock.

ReposiTrak Company Profile

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.